Nestcoin is Yele Bademosi’s latest crypto venture. In the last decade, bitcoin and other cryptocurrencies (and their underlying blockchains) have teased eye-catching use cases for […]
Continue reading
USD 200M Avalanche, NFTs Get Grammy & USD 100M, Wall Street Hunts For Crypto Pros + More News
Source: Adobe/Kevin Get your daily, bite-sized digest of cryptoasset and blockchain-related news – investigating the stories flying under the radar of today’s crypto news. ____ […]
Continue reading
AMD: Here’s What I Am Doing After Another Blowout Earnings
Summary AMD is no longer an “underdog”, and future growth projections do not necessarily justify its current valuation. In this note, we review AMD’s Q3 […]
Continue reading
Teledoc Needs at Least a Year to Prove Itself to Investors
After Teledoc Health (NYSE: TDOC ) merged with Livongo last year, the stock underperformed. And now, after a brief surge in early 2021, TDOC stock […]
Continue readingDeFi Total Value Locked Hits All-Time High of $236 Billion
NEW YORK, Nov. 1, 2021 /PRNewswire/ — The Decentralized Finance (DeFi) market made a massive rebound in October after a month-long lull, with total value […]
Continue reading
VanEck Russia: A Great Time To Invest
The Ruble is gaining on the dollar. Economic developments suggest Russia is cheap. Russia has a strong foundation. Сергей Шармаков/iStock via Getty Images Preamble At […]
Continue reading
Maersk to invest $136 million for 205,000 sq m logistics park in Saudi
Maersk to invest $136 million for 205,000 sq m logistics park in Saudi By Our Correspondent November 1, 2021: A. P. Moller – Maersk signed […]
Continue reading
How to start investing safely and profitably
Have the spare cash Inflation is running at 3.1% , and finding a savings account paying above that is impossible. But many experts claim you […]
Continue reading
Investing Basics: Small-Cap Stocks
Editorial Note: Forbes Advisor may earn a commission on sales made from partner links on this page, but that doesn’t affect our editors’ opinions or […]
Continue reading
Five Considerations After Teva Pharmaceuticals’ Q3 Report
Summary TEVA stock is down irrationally after its quarterly earnings report. Shares traded at a 2021 forward P/E in the 3 times range. Outlook reaffirmed. […]
Continue reading
Protected by Patchstack